CL2014001112A1 - Composicion que comprende entre 4 a 12% en peso de complejo de yodo-povidona, 0,1 a 2% de una amida terciaria, sal de amida terciaria y/o hidrato de amida terciaria, 0,5 a 2% de emoliente con baja reactividad al yodo, al menos un tensoactivo y agua. - Google Patents

Composicion que comprende entre 4 a 12% en peso de complejo de yodo-povidona, 0,1 a 2% de una amida terciaria, sal de amida terciaria y/o hidrato de amida terciaria, 0,5 a 2% de emoliente con baja reactividad al yodo, al menos un tensoactivo y agua.

Info

Publication number
CL2014001112A1
CL2014001112A1 CL2014001112A CL2014001112A CL2014001112A1 CL 2014001112 A1 CL2014001112 A1 CL 2014001112A1 CL 2014001112 A CL2014001112 A CL 2014001112A CL 2014001112 A CL2014001112 A CL 2014001112A CL 2014001112 A1 CL2014001112 A1 CL 2014001112A1
Authority
CL
Chile
Prior art keywords
tertiary amide
iodine
emollient
surfactant
composition
Prior art date
Application number
CL2014001112A
Other languages
English (en)
Inventor
Peter Lentini
Original Assignee
Microdermis Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=48192689&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=CL2014001112(A1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Microdermis Corp filed Critical Microdermis Corp
Publication of CL2014001112A1 publication Critical patent/CL2014001112A1/es

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/44Oils, fats or waxes according to two or more groups of A61K47/02-A61K47/42; Natural or modified natural oils, fats or waxes, e.g. castor oil, polyethoxylated castor oil, montan wax, lignite, shellac, rosin, beeswax or lanolin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00Medicinal preparations containing inorganic active ingredients
    • A61K33/18Iodine; Compounds thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/16Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing nitrogen, e.g. nitro-, nitroso-, azo-compounds, nitriles, cyanates
    • A61K47/18Amines; Amides; Ureas; Quaternary ammonium compounds; Amino acids; Oligopeptides having up to five amino acids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0014Skin, i.e. galenical aspects of topical compositions
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/10Dispersions; Emulsions

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Dermatology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Inorganic Chemistry (AREA)
  • Dispersion Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Preparation (AREA)
  • Cosmetics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Detergent Compositions (AREA)
  • Compositions Of Macromolecular Compounds (AREA)
CL2014001112A 2011-10-31 2014-04-29 Composicion que comprende entre 4 a 12% en peso de complejo de yodo-povidona, 0,1 a 2% de una amida terciaria, sal de amida terciaria y/o hidrato de amida terciaria, 0,5 a 2% de emoliente con baja reactividad al yodo, al menos un tensoactivo y agua. CL2014001112A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US201161553503P 2011-10-31 2011-10-31

Publications (1)

Publication Number Publication Date
CL2014001112A1 true CL2014001112A1 (es) 2014-07-11

Family

ID=48192689

Family Applications (1)

Application Number Title Priority Date Filing Date
CL2014001112A CL2014001112A1 (es) 2011-10-31 2014-04-29 Composicion que comprende entre 4 a 12% en peso de complejo de yodo-povidona, 0,1 a 2% de una amida terciaria, sal de amida terciaria y/o hidrato de amida terciaria, 0,5 a 2% de emoliente con baja reactividad al yodo, al menos un tensoactivo y agua.

Country Status (11)

Country Link
US (3) US20130121953A1 (es)
EP (1) EP2773201B1 (es)
AR (1) AR088600A1 (es)
BR (1) BR112014010564A2 (es)
CL (1) CL2014001112A1 (es)
CO (1) CO7010827A2 (es)
CR (1) CR20140186A (es)
EC (1) ECSP14002959A (es)
HK (1) HK1201687A1 (es)
PE (1) PE20141580A1 (es)
WO (1) WO2013066909A1 (es)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2688410B1 (en) * 2011-03-25 2017-08-09 DeLaval Holding AB Low surfactant iodine topical disinfectant
CA2990627A1 (en) * 2015-06-22 2016-12-29 Infection Containment Company, LLC Topical antiseptic system
CN113318122B (zh) * 2021-03-24 2022-06-24 厦门大开生物科技有限公司 一种含有聚维酮碘的消毒剂组合物及其用途

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5716611A (en) * 1996-01-02 1998-02-10 Euro-Celtique, S.A. Emollient antimicrobial formulations containing povidone iodine
US6436379B1 (en) * 1997-10-17 2002-08-20 International Flora Technologies Ltd. Emollient for cuticle treatment and delivery system therefore
US6559182B1 (en) * 2001-11-07 2003-05-06 Purcell Jojoba International, Llc Method for treatment of enveloped viruses using jojoba oil esters
AU2003299034A1 (en) * 2002-09-20 2004-04-08 Griscom Bettle Iii Transdermal compositions
EP2566488B1 (en) * 2010-05-07 2016-07-13 Microdermis Corporation Povidone-iodine topical composition

Also Published As

Publication number Publication date
US20180243424A1 (en) 2018-08-30
AR088600A1 (es) 2014-06-18
US20130121953A1 (en) 2013-05-16
US20190117783A1 (en) 2019-04-25
HK1201687A1 (en) 2015-09-11
WO2013066909A1 (en) 2013-05-10
EP2773201A1 (en) 2014-09-10
PE20141580A1 (es) 2014-11-20
BR112014010564A2 (pt) 2017-04-25
CO7010827A2 (es) 2014-07-31
EP2773201B1 (en) 2017-12-06
EP2773201A4 (en) 2015-05-20
CR20140186A (es) 2014-08-28
ECSP14002959A (es) 2017-05-31

Similar Documents

Publication Publication Date Title
BR112013025732A2 (pt) composto de imidazo-oxazina ou sal do mesmo
EP2768539A4 (en) ANTIMICROBIAL FORMULATIONS WITH PELARGONIC ACID
GT201200192A (es) Composición acuosa antitranspirante / desodorante
CL2013001589A1 (es) Uso de una emulsion que comprende 0,08% en peso o menos de aceite esencial antimicrobiano, goma acacia y agua para proporcionar un efecto antimicrobiano en una composicion acuosa; proceso para mejorar el efecto antimicrobiano de un aceite esencial antimicrobiano; y composicion acuosa que comprende una emulsion antimicrobiana.
AR093794A1 (es) Composiciones conteniendo fosfato de zinc
CR20150663A (es) Derivados de diazacarbazol como ligandos de tau para pet
HN2012000182A (es) Formulacion farmaceutica
BR112014007078A2 (pt) composição de controle de doença de plantas e seu uso
MX344473B (es) Composicion farmaceutica acuosa semisolida que contiene tapentadol.
BR112014000221A2 (pt) composição de gel
MX349241B (es) Sal de aluminio que contiene alto porcentaje de ai30 referencia cruzada a solicitudes relacionadas.
BR112015021332A2 (pt) sal de sódio de ácido (2s, 5r)-6-benzilóxi-7-oxo-1,6-diaza-biciclo [3.2.1] octano-2-carboxílico e sua preparação
AR082422A1 (es) Composicion detergente liquida
CR20130473A (es) Genes que proporcionan resistencia al mildiú polvoroso en cucumis melo
EP2718808A4 (en) BINDING EXECUTABLE CODES AT A TIME
BR112013002312A2 (pt) estabilização de fsh
BR112014026198A2 (pt) compostos pirazol como inibidores de sglt1
ECSP14013250A (es) Suspension concentrada acuosa que comprende una sal ácida de dodecilguanidina
MX2015014575A (es) Barra de jabon que tiene actividad antibacteriana mejorada.
BR112014015381A2 (pt) meio de filtração compreendendo um sulfeto metálico
CL2014001112A1 (es) Composicion que comprende entre 4 a 12% en peso de complejo de yodo-povidona, 0,1 a 2% de una amida terciaria, sal de amida terciaria y/o hidrato de amida terciaria, 0,5 a 2% de emoliente con baja reactividad al yodo, al menos un tensoactivo y agua.
EP2696690A4 (en) SULFATE SALTS AS RUNNING AMPLIFIERS
EP2835443A4 (en) CR-MAKING AUSTENITIC ALLOY
AR087787A1 (es) Compuesto de benzotiazolona
CL2015003350A1 (es) Composiciones para el cuidado bucal